Matches in Nanopublications for { ?s ?p "[Data show thatP446L polymorphism carriers are protected against type 2 diabetes despite higher triglyceride levels and risk of dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP141928.RACrCDXY18namSbiJfA0N14r_a_qZKH-Tw41eEharyJkE130_assertion description "[Data show thatP446L polymorphism carriers are protected against type 2 diabetes despite higher triglyceride levels and risk of dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP141928.RACrCDXY18namSbiJfA0N14r_a_qZKH-Tw41eEharyJkE130_provenance.
- assertion description "[Data show thatP446L polymorphism carriers are protected against type 2 diabetes despite higher triglyceride levels and risk of dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP205071.RAQrl67m-CJtKH8ZqlizydcaSH3Ax8Th1qpvi315sdihA130_assertion description "[Data show thatP446L polymorphism carriers are protected against type 2 diabetes despite higher triglyceride levels and risk of dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP205071.RAQrl67m-CJtKH8ZqlizydcaSH3Ax8Th1qpvi315sdihA130_provenance.
- NP238875.RAk6fvNIYeqccY8OT8id-NwQuQDCODtzRc-1sJdyAUqZ4130_assertion description "[Data show thatP446L polymorphism carriers are protected against type 2 diabetes despite higher triglyceride levels and risk of dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238875.RAk6fvNIYeqccY8OT8id-NwQuQDCODtzRc-1sJdyAUqZ4130_provenance.